CurrentEndo coverage · page 51 of 55

Diabetes, Obesity and Metabolism

Briefs 2,001–2,040 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab29 May 2023
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
Research articleObesity
Diabetes Obes Metab29 May 2023
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme
Secondary analysisT2D & other
Diabetes Obes Metab29 May 2023
The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system
Cohort studyTechnology
Diabetes Obes Metab29 May 2023
Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study
Cohort studyT2D & other
Diabetes Obes Metab25 May 2023
Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial
Randomized controlled trialComplications
Diabetes Obes Metab24 May 2023
The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention?
Research articleObesity
Diabetes Obes Metab22 May 2023
Stabilization of kidney function and reduction in heart failure events with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis and meta‐regression analysis
Meta-analysisT2D & other
Diabetes Obes Metab18 May 2023
Altered high‐density lipoprotein composition is associated with risk for complications in type 2 diabetes mellitus in South Asian descendants: A cross‐sectional, case‐control study on lipoprotein subclass profiling
Case-control studyT2D & other
Diabetes Obes Metab18 May 2023
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational study
Cohort studyT1D
Diabetes Obes Metab18 May 2023
Sodium‐glucose cotransporter‐2 inhibitors and kidney outcomes in real‐world type 2 diabetes populations: A systematic review and meta‐analysis of observational studies
Meta-analysisT2D & other
Diabetes Obes Metab15 May 2023
Effect of the glucagon‐like peptide‐1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
Randomized controlled trialT2D & other
Diabetes Obes Metab15 May 2023
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials
Meta-analysisT2D & other
Diabetes Obes Metab11 May 2023
Long‐acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population‐based cohort study
Cohort studyT2D & other
Diabetes Obes Metab10 May 2023
Bile acid metabolites in early pregnancy and risk of gestational diabetes mellitus: Results from a prospective cohort study
Cohort studyDiabetes in pregnancy
Diabetes Obes Metab10 May 2023
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
Secondary analysisT2D & other
Diabetes Obes Metab8 May 2023
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub‐analysis of the DIVERSITY‐CVR study
Secondary analysisT2D & other
Diabetes Obes Metab8 May 2023
Effect of multifactorial intensive treatment in patients with diabetic kidney disease: A meta‐analysis with trial sequential analysis
Meta-analysisComplications
Diabetes Obes Metab8 May 2023
Incidence and predictors of remission and relapse of type 2 diabetes mellitus in Japan: Analysis of a nationwide patient registry (JDDM73)
Cohort studyT2D & other
Diabetes Obes Metab8 May 2023
The improved health utility of once‐weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1‐4 obesity trials
Secondary analysisObesity
Diabetes Obes Metab8 May 2023
Use of hospital care among Dutch diabetes patients
Cohort studyT2D & other
Diabetes Obes Metab4 May 2023
Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study
Cohort studyT1D
Diabetes Obes Metab4 May 2023
Brain insulin responsiveness is linked to age and peripheral insulin sensitivity
Mechanistic study
Diabetes Obes Metab3 May 2023
Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double‐blind randomized crossover pilot trial
Randomized controlled trialObesity
Diabetes Obes Metab3 May 2023
Glycated albumin and risk of cardiovascular diseases and mortality in patients with and without dialysis: A meta‐analysis
Meta-analysisComplications
Diabetes Obes Metab3 May 2023
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi‐heart study
Randomized controlled trialT2D & other
Diabetes Obes Metab3 May 2023
Continuous glucose monitoring in patients with post‐bariatric hypoglycaemia reduces hypoglycaemia and glycaemic variability
Research articleTechnology
Diabetes Obes Metab3 May 2023
iGlarLixi provides a higher derived time‐in‐range versus insulin glargine 100 U / mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis
Secondary analysisT2D & other
Diabetes Obes Metab3 May 2023
Longitudinal study investigating serum metabolites and their association with type 2 diabetes risk in a Korean population
Cohort studyT2D & other
Diabetes Obes Metab3 May 2023
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus
Randomized controlled trialT1D
Diabetes Obes Metab27 Apr 2023
A randomized Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist, in healthy Japanese men with overweight/obesity
Randomized controlled trialObesity
Diabetes Obes Metab26 Apr 2023
Efficacy and safety of once‐weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE‐D , AMPLITUDE‐L and AMPLITUDE‐S randomized controlled trials
Randomized controlled trialT2D & other
Diabetes Obes Metab25 Apr 2023
A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID ‐19
Cohort studyT1D
Diabetes Obes Metab24 Apr 2023
Assessment of circulating insulin using liquid chromatography‐mass spectrometry during insulin glargine treatment in type 2 diabetes: Implications for estimating insulin sensitivity and β‐cell function
Mechanistic studyT2D & other
Diabetes Obes Metab24 Apr 2023
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase 2 trial
Randomized controlled trialT2D & other
Diabetes Obes Metab20 Apr 2023
Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia
Randomized controlled trialT2D & other
Diabetes Obes Metab19 Apr 2023
Association of glycation gap with all‐cause and cardiovascular mortality in US adults: A nationwide cohort study
Cohort study
Diabetes Obes Metab16 Apr 2023
Identification of predictive factors of diabetic ketoacidosis in type 1 diabetes using a subgroup discovery algorithm
Cohort studyT1D
Diabetes Obes Metab13 Apr 2023
Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges
Research articleTechnology
Diabetes Obes Metab11 Apr 2023
Clinical features of generalized lipodystrophy in Turkey: A cohort analysis
Cohort studyObesity
Diabetes Obes Metab11 Apr 2023
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL , a randomized trial
Randomized controlled trialComplications

All 2,200 Briefs in ExploreShowing Briefs 2,001–2,040 of 2,200, newest first